Where is the share price?

The price at the top of this page is the last traded price from exchange data.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings.

Does Tradinity give buy or sell advice?

No. The scores and checklist are rule-based summaries of published figures, not recommendations.

Pfizer Limited | Tradinity

Key Metrics

Preset

Market Capitalization

₹17,729 Cr

PE (TTM)

24.1

Industry median 36.1 (152 companies)

Price to Book

4.2

PEG (TTM)

Data unavailable (needs 8 quarters of EPS).

Institutions holding %

19.45%

FII + DII, latest filed period

Piotroski Score

5

Relative return vs Nifty50, qtr %

-6.3

Relative return vs Sector, qtr %

-13.4

Free Cash Flow

₹942 Cr

as of March 31, 2026

Industry median ₹-0 Cr (198 companies)

EPS Growth (YoY)

6.63%

as of June 30, 2026

Industry median 26.14% (180 companies)

Net Profit Growth (TTM)

-11.61%

as of June 30, 2026

Industry median 6.21% (175 companies)

Operating Revenue Growth (TTM)

9.52%

as of June 30, 2026

Industry median 9.08% (175 companies)

Profit Growth (YoY)

6.63%

as of June 30, 2026

Industry median 22.20% (176 companies)

Revenue Growth (YoY)

8.31%

as of June 30, 2026

Industry median 14.05% (173 companies)

Current Ratio

6.06

as of March 31, 2026

Industry median 1.84 (197 companies)

Debt to Equity

0.00

as of March 31, 2026

Industry median 0.14 (186 companies)

Interest Coverage

130.11

as of June 30, 2026

Industry median 10.58 (182 companies)

Net Margin

31.30%

as of June 30, 2026

Industry median 9.35% (179 companies)

Operating Margin (EBIT)

42.58%

as of June 30, 2026

Industry median 14.22% (181 companies)

Operating Margin (TTM)

38.93%

as of June 30, 2026

Industry median 12.41% (182 companies)

Return on Assets

14.68%

as of March 31, 2026

Industry median 5.54% (180 companies)

Return on Capital Employed

22.94%

as of March 31, 2026

Industry median 12.43% (181 companies)

Return on Equity

17.19%

as of March 31, 2026

Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

5 of 8 met

No Net profit is higher than a year earlier in each of the last 4 quarters
Yes Revenue is higher than a year earlier in each of the last 4 quarters
Yes Quality score is Strong (70 or more)
No Piotroski F-score is 7 or more (score 5)
Yes Debt to equity is below 0.5 (0.00)
Yes Return on equity is 15% or more (17.2%)
No Net cash flow for the latest year is positive
Yes Cash from operations is higher than the year before

Ownership

3 of 3 met

Yes FII/FPI or DII holding rose in the latest quarter
Yes Promoter holding rose or was unchanged in the latest quarter
Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met

No 1-year return beats the industry median
No Revenue growth beats the industry median
No Profit growth beats the industry median

Value and momentum

1 of 6 met

Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
No Valuation score is Undervalued (70 or more)
No Momentum score is Bullish (70 or more)
No Price is above the 5, 10 and 20 day averages
No Price is above the 50, 100 and 200 day averages
No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return

-1.0%

Low 3833.5000 · High 3933.8000

1W return

-3.7%

Low 3833.5000 · High 4066.0000

1M return

-17.3%

Low 3833.5000 · High 4707.8000

52W return

-24.8%

Low 3833.5000 · High 5578.5000

Lifetime High ₹6318.3000 (Sept. 2, 2024)

Lifetime Low ₹178.6500 (Dec. 4, 1996)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0

Bearish6

5D

3941.4

10D

4003.8

20D

4150.0

50D

4397.8

100D

4539.6

200D

4707.7

Delivery and volume

Day avg. delivery

66.1%

Week avg. delivery

62.1%

Month avg. delivery

59.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

3880.87

Pivot

First resistance3928.23

Second resistance3981.17

Third resistance4028.53

First support3827.93

Second support3780.57

Third support3727.63

Day RSI19.4

Day MFI6.2

Day MACD-190.98

Day MACD signal-187.13

Beta

1M0.44

3M0.58

1Y0.63

3Y0.43

Price change analysis

↓ -17.3%

Over 1 Month

LowHigh

3833.504707.80

↓ -13.4%

Over 3 Months

LowHigh

3833.505149.00

↓ -20.1%

Over 6 Months

LowHigh

3833.505149.00

↓ -24.8%

Over 1 Year

LowHigh

3833.505578.50

Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Current PE 24.1 (own history: 26.7–48.9)

Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →

Revenue (June 30, 2026)

₹653 Cr

Net profit (June 30, 2026)

₹204 Cr

Basic EPS (June 30, 2026)

₹44.6900

Ranks #30 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026

Promoter63.92%
Mutual funds12.68%
FII/FPI1.65%
Other DII5.12%
Public16.63%

Largest holders

Name	Category	Shares %	Shares
PFIZER EAST INDIA B V	Promoter	39.7500%	18186334
WYETH LLC	Promoter	12.2800%	5617707
NIPPON LIFE INDIA TRUSTEE LTD	Public	4.1700%	1906535
LIFE INSURANCE CORPORATION OF INDIA	Public	3.7400%	1709223
WYETH HOLDINGS CORPORATION	Promoter	3.5600%	1630164

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 63.92% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 2.81% to 1.65% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 11.52% to 12.68% in Jun 2026 qtr

22 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 5 insider trades, 5 SAST, 0 pledge events →

Latest insider trades

Filed	Person	Category	Type	Value
4 May 2020	Anil Gupta	Employee / designated person	Buy	₹0
4 May 2020	Anil Gupta	Employee / designated person	Buy	₹0
4 May 2020	Anil Gupta	Employee / designated person	Buy	₹0
4 May 2020	Anil Gupta	Employee / designated person	Sell	₹0
4 May 2020	Anil Gupta	Employee / designated person	Buy	₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 6 deals, with filters and CSV →

Date	Client	Deal	Action	Quantity	Price	Exchange
20 Aug 2026	QUANT MUTUAL FUND	Bulk	Buy	267,864	4899.9700	BSE
24 Apr 2026	PRUDENTIAL ICICI MUTUAL FUND A/C DISCOVERY FUND	Bulk	Buy	400,000	4700.0000	BSE
24 Apr 2026	GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO	Bulk	Sell	426,066	4700.0100	BSE
5 Dec 2007	BIRLA SUNLIFE TRUSTEE CO PVT LTD AC INDIA EXCEL OFFSHORE FUND	Bulk	Sell	180,352	685.0000	BSE
5 Dec 2007	RELIANCE CAPITAL TRUSTEE CO LTD AC RELIANCE TAX SAVER FUND	Bulk	Buy	200,215	685.0000	BSE
13 Jul 2007	FIDELITY TRUSTEE CO PVT LTD FIDELITY EQUITY FUND	Bulk	Sell	157,247	803.0000	BSE

All bulk and block deals →

Dividends

Full dividend history →

Last 12 months ₹75.00 per share

Dividend yield 1.94%

Ex-date	Subject	Per share (₹)	Record date
17 Jul 2026	Dividend - Rs 75 Per Share	75.0000	17 Jul 2026
9 Jul 2025	Dividend - Rs 35 Per Share & Special Dividend Of Rs 100 Per Share/ Special Dividend Of Rs 30	35.0000	9 Jul 2025
21 Aug 2024	Dividend - Rs 35 Per Share	35.0000	21 Aug 2024
11 Aug 2023	Dividend - Rs 35 Per Share/ Special Dividend - Rs 5 Per Share	35.0000	11 Aug 2023
19 Sep 2022	Special Dividend - Rs 30 Per Share	30.0000	20 Sep 2022
18 Aug 2022	Dividend - Rs 35 Per Share	35.0000	19 Aug 2022
11 Aug 2021	Annual General Meeting/Dividend - Rs 30 Per Share/Special Dividend - Rs 5 Per Share	30.0000	—
27 Aug 2020	Annual General Meeting/Dividend - Rs 10 Per Share	10.0000	—
6 May 2020	Special Dividend - Rs 320 Per Share	320.0000	8 May 2020
1 Aug 2019	Dividend - Rs 22.50 Per Share	22.5000	—

Corporate Actions

Full history (25 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-date	Type	Subject
29 Oct 2014	OTHER	Annual General Meeting
15 Apr 2010	OTHER	Div-Rs.12.50 Per Share
9 Mar 2007	AGM	Agm/Div-Rs.22.50 Per Sh Purpose Revised
10 Apr 2006	AGM	Agm/Div-Rs.10/- Per Share

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

Date	Purpose	Results
28 Jul 2026	Financial Results	Yes
12 May 2026	Financial Results/Dividend	Yes
9 Feb 2026	Financial Results	Yes
12 Nov 2025	Financial Results	Yes
13 Aug 2025	Financial Results	Yes

Corporate Announcements

All 645 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

Date	Category	Announcement
2 Oct 2026	Copy of Newspaper Publication	Pfizer Limited has informed the Exchange about Copy of Newspaper Publication
2 Oct 2026	Company Update	Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Newspaper Publication
29 Sep 2026	Trading Window	Pfizer Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
29 Sep 2026	Action(s) initiated or orders passed	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has, on September 28, 2026, received an Order dated September 25, 2026, issued by the Deputy / Additional Commissioner of Income tax Transfer Pricing, levying a penalty of Rs. 1,26,34,050/- based on the Transfer Pricing audit conducted for the Assessment Year 2023-24.
29 Sep 2026	Insider Trading / SAST	Pfizer Ltd - 500680 - Closure of Trading Window
29 Sep 2026	Company Update	Pfizer Ltd - 500680 - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
18 Sep 2026	Company Update	Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Change in Management
18 Sep 2026	Resignation of Director/KMP/SMP	Pfizer Limited has informed the Exchange about Resignation of Director/KMP/SMP
18 Sep 2026	Resignation of Director/KMP/SMP	Pfizer Limited has informed the Exchange about Resignation of Director/KMP/SMP
18 Sep 2026	Change in Management	Pfizer Limited has informed the Exchange about change in Management

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Strong net profit margin (31.3%)
Low financial leverage (Debt/Equity 0.00)
Comfortable interest coverage (130.1x)

Weaknesses

Data unavailable.

Opportunities

RSI in oversold territory (19.4) -- a technical rebound zone

Threats

Down 24.8% over the past year

F&O

View F&O, Options & Backtest →

Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.

Pfizer Limited

Key Metrics

Investment checklist

Financials

Ownership

Peer comparison

Value and momentum

Price

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Price range

Technicals

EMA & SMA

Delivery and volume

Resistance and support

Beta

Price change analysis

Buy/Sell Zone

Financials

Shareholding pattern / Ownership

Shareholding summary

Largest holders

Historical promoter holding

Historical fii holding

Historical mutual fund holding

Insider trading, SAST & pledges

Latest insider trades

Deals (Bulk & Block)

Dividends

Corporate Actions

Board Meetings

Corporate Announcements

SWOT

Strengths

Weaknesses

Opportunities

Threats

F&O

Frequently asked questions about Pfizer Limited